Medios AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
165.20
33.20
739.00
3,474.00
4,134.00
4,326.80
Depreciation, Depletion & Amortization
15.40
-
38.00
107.00
491.00
1,142.10
Other Funds
123.00
183.20
257.00
8,356.00
269.00
2,761.10
Funds from Operations
26.70
150.10
1,034.00
4,989.00
4,697.00
8,980
Changes in Working Capital
35.10
136.80
266.00
6,574.00
3,970.00
12,136.20
Net Operating Cash Flow
8.40
13.30
1,300.00
1,585.00
727.00
3,156.10
Capital Expenditures
0.20
-
119.00
373.00
5,341.00
Sale of Fixed Assets & Businesses
0.10
-
-
-
-
Purchase/Sale of Investments
-
-
-
-
100.00
Net Investing Cash Flow
0.10
-
119.00
373.00
16,010.00
Cash Dividends Paid - Total
-
0.90
-
-
-
Net Financing Cash Flow
0.90
0.90
25.00
17,739.00
14,879.00
Net Change in Cash
9.20
12.40
1,206.00
15,781.00
404.00
Free Cash Flow
8.20
13.30
1,189.00
1,898.00
3,266.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
197.00
750
Net Assets from Acquisitions
-
-
-
-
10,569.00
Change in Capital Stock
0.90
-
25.00
17,739.00
14,879.00

About Medios

View Profile
Address
Friedrichstrasse 113a
Berlin Berlin 10117
Germany
Employees -
Website http://www.medios.ag
Updated 07/08/2019
Medios AG engages in providing specialty pharmaceutical drugs. These are medicines for patients with rare or chronic diseases such as cancer, HIV and hepatitis, whose personalized therapy is often tedious and cost-intensive due to their individual requirements. It operates through the following segments: Specialty Pharma Trade, Personalized Preparations, and Shared Services.